Intellia Therapeutics, Inc. (NTLA) News
Track canonical SquawkNews coverage tagged to NTLA, Intellia Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
NTLA - Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
NTLA - Intellia Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates
EARNINGS | Aug 06, 2026, 11:00 AM UTC
L
NTLA - Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business Updates - Cli
NTLA - Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business Updates
EARNINGS | Jul 30, 2026, 12:00 PM UTC
L
NTLA Downgrade from Peerperform to Underperform W/$9.00 PT at Wolfe Research
NTLA Downgrade from Peerperform to Underperform W/$9.00 PT at Wolfe Research
EQUITY | Jul 16, 2026, 11:54 AM UTC
L
NTLA downgraded from Peer Perform to Underperform W/ $9 PT @ Wolfe
NTLA downgraded from Peer Perform to Underperform W/ $9 PT @ Wolfe
EQUITY | Jul 16, 2026, 11:23 AM UTC